4Tissue is a Belgian medtech company based in Ghent that develops bioresorbable, injectable hydrogels for tissue reconstruction and regeneration. Its lead candidate, Tissurel, encapsulates autologous fat or stem cells to support natural tissue regeneration and is in development for breast reconstruction and augmentation after breast cancer, offering a less invasive alternative to silicone implants or flap surgery. Founded in 2023 as a Ghent university spin-off, the company is preparing first-in-human clinical studies and extending its hydrogel platform to further soft-tissue repair applications.
1
Round
1
Industry
5
Tags
Oct 20, 2026
Latest raise
Funding activity · 1 round
Oct 20, 2026
EUR 7M
Series A
Led by Virginie Saverys
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
